ImmunoGen, Inc. Announces Clinical Data Presentations at Upcoming 55(th ... Wall Street Journal Title: "Phase II Study of Anti-CD19 Antibody Drug Conjugate (SAR3419) in Combination with Rituximab: Clinical Activity and Safety in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma" (Abstract #4395). -- Poster session #624: Dec. |
